Impact of Stone Disease. Chronic Kidney Disease and Quality of Life.

Urologic Clinics of North America

Volumn 40, Issue 1, 2013, Pages 135-147

  Kartha, Ganesh ^a   Calle, Juan C ^a   Marchini, Giovanni Scala ^a   Monga, Manoj ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chronic kidney disease; Nephrolithiasis; Quality of life; Renal function

Indexed keywords

CREATININE;

CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISTRESS SYNDROME; EARLY INTERVENTION; EXTRACORPOREAL LITHOTRIPSY; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; HYPERTENSION; INFECTION RISK; INTERMETHOD COMPARISON; KIDNEY FAILURE; NEPHROLITHIASIS; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PERCUTANEOUS NEPHROLITHOTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; SHORT FORM 36;

DISEASE PROGRESSION; HUMANS; QUALITY OF LIFE; RENAL INSUFFICIENCY, CHRONIC; UROLITHIASIS;

EID: 84870226175     PISSN: 00940143     EISSN: 1558318X     Source Type: Journal    
DOI: 10.1016/j.ucl.2012.09.004     Document Type: Review

References (123)

1. Lotan Y. Economics and cost of care of stone disease. Adv Chronic Kidney Dis 2009, 16(1):5-10.
2. Pearle M.S., Calhoun E.A., Curhan G.C. Urologic diseases in America project: urolithiasis. J Urol 2005, 173(3):848-857.
3. Stamatelou K.K., Francis M.E., Jones C.A., et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003, 63(5):1817-1823.
4. Lieske J.C., Peña de la Vega L.S., Slezak J.M., et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 2006, 69(4):760-764.
5. Taylor E.N., Stampfer M.J., Curhan G.C. Obesity, weight gain, and the risk of kidney stones. JAMA 2005, 293:455-462.
6. Taylor E.N., Stampfer M.J., Curhan G.C. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 2005, 68(3):1230-1235.
7. Romero V., Akpinar H., Assimos D.G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 2010, 12(2-3):e86-e96.
8. Lamson O.F. Recurrent nephrolithiasis. Ann Surg 1920, 71(1):16-21.
9. Hall P.M. Nephrolithiasis: treatment, causes, and prevention. Cleve Clin J Med 2009, 76(10):583-591.
10. Coe F.L., Keck J., Norton E.R. The natural history of calcium urolithiasis. JAMA 1977, 238(14):1519-1523.
11. Williams R.E. Long-term survey of 538 patients with upper urinary tract stone. Br J Urol 1963, 35:416-437.
12. Borghi L., Schianchi T., Meschi T., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002, 346:77-84.
13. Poullain J., Devevey J.M., Mousson C., et al. Management of lithiasis of kidney transplant. Prog Urol 2010, 20(2):138-143.
14. Challacombe B., Dasgupta P., Tiptaft R., et al. Multimodal management of urolithiasis in renal transplantation. BJU Int 2005, 96(3):385-389.
15. Stravodimos K.G., Adamis S., Tyritzis S., et al. Renal transplant lithiasis: analysis of our series and review of the literature. J Endourol 2012, 26(1):38-44.
16. Griffen W.O., Bivins B.A., Bell R.M. The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet 1983, 157(4):301-308.
17. Requarth J.A., Burchard K.W., Colacchio T.A., et al. Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal. Arch Surg 1995, 130(3):318-325.
18. Sinha M.K., Collazo-Clavell M.L., Rule A., et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 2007, 72(1):100-107.
19. Lieske J.C., Kumar R., Collazo-Clavell M.L. Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol 2008, 28(2):163-173.
20. Durrani O., Morrisroe S., Jackman S., et al. Analysis of stone disease in morbidly obese patients undergoing gastric bypass surgery. J Endourol 2006, 20(10):749-752.
21. Milliner D.S., Wilson D.M., Smith L.H. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int 2001, 59(1):31-36.
22. Harambat J., Fargue S., Bacchetta J., et al. Primary hyperoxaluria. Int J Nephrol 2011, 2011:864580.
23. Griffith D.P. Struvite stones. Kidney Int 1978, 13(5):372-382.
24. Rodman J.S. Struvite stones. Nephron 1999, 81(Suppl 1):50-59.
25. Font-Llitjós M., Jiménez-Vidal M., Bisceglia L., et al. New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet 2005, 42(1):58-68.
26. Milliner D.S. Cystinuria. Endocrinol Metab Clin North Am 1990, 19(4):889-907.
27. Shekarriz B., Stoller M.L. Cystinuria and other noncalcareous calculi. Endocrinol Metab Clin North Am 2002, 31:951-977.
28. Saigal C.S., Joyce G., Timilsina A.R. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?. Kidney Int 2005, 68(4):1808-1814.
29. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
30. United States renal data system. 2011 annual data report. Available at: Accessed October 15, 2012. http://www.usrds.org/adr.aspx.
31. Couser W.G., Riella M.C., Joint International Society of Nephrology, International Federation of Kidney Foundations World Kidney Day 2011 Steering Committee World Kidney Day 2011: protect your kidneys, save your heart. Clin J Am Soc Nephrol 2011, 6(2):235-238.
32. Goel M.C., Ahlawat R., Kumar M., et al. Chronic renal failure and nephrolithiasis in a solitary kidney: role of intervention. J Urol 1997, 157:1574.
33. Gupta N.P., Kochar G.S., Wadhwa S.N., et al. Management of patients renal and ureteric calculi presenting with chronic renal insufficiency. Br J Urol 1985, 57:130.
34. Gupta M., Bolton D.M., Gupta P.N., et al. Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency. J Urol 1994, 152:1086.
35. Marangella M., Bruno M., Cosseddu D., et al. Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron 1990, 54:302.
36. Gambaro G., D'Angelo A., Favaro S. Risk for renal failure in nephrolithiasis. Am J Kidney Dis 2001, 37:233.
37. Frymoyer P.A., Scheinman S.J., Dunham P.B., et al. X-linked recessive nephrolithiasis with renal failure. N Engl J Med 1991, 325:681-686.
38. Leumann E.P. Primary hyperoxaluria: an important cause of renal failure in infancy. Int J Pediatr Nephrol 1985, 6:13-16.
39. Worcester E.M., Coe F.L., Evan A.P., et al. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int 2006, 97:1285-1290.
40. Jungers P., Joly D., Barbey F., et al. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 2004, 44:799-805.
41. Worcester E., Parks J.H., Josephson M.A., et al. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 2003, 64:2204-2213.
42. Gillen D.L., Worcester E.M., Coe F.L. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 2005, 67:685-690.
43. Vupputuri S., Soucie J.M., McClellan W., et al. History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 2004, 14:222-228.
44. Rule A.D., Bergstralh E.J., Melton L.J., et al. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:804-811.
45. Craver L., Marco M.P., Martínez I., et al. Mineral metabolism parameters throughout chronic kidney disease stages 1-5: Achievement of K/DOQI target ranges. Nephrol Dial Transplant 2007, 22:1171-1176.
46. Tosetto E., Graziotto R., Artifoni L., et al. Dent's disease and prevalence of renal stones in dialysis patients in Northeastern Italy. J Hum Genet 2006, 51:25-30.
47. Collins A.J., Foley R.N., Herzog C., et al. US renal data system 2010 annual data report. Am J Kidney Dis 2001, 57(Suppl 1). A8, e521-A8, e526.
48. Stankus N., Hammes M., Gillen D., et al. African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res 2007, 35:83-87.
49. Hippisley-Cox J., Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney scores. BMC Fam Pract 2010, 11:49.
50. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 16:461-470.
51. Bilen C.Y., Inci K., Kocak B., et al. Impact of percutaneous nephrolithotomy on estimated glomerular filtration rate in patients with chronic kidney disease. J Endourol 2008, 22:895-900.
52. Lotan Y., Pearle M.S. Economics of stone management. Urol Clin North Am 2007, 34:443-453.
53. Preminger G.M., Tiselius H.G., Assimos D.G., et al. 2007 Guideline for the management of ureteral calculi. Eur Urol 2007, 52:1610-1631.
54. Preminger G.M., Tiselius H.G., Assimos D.G., et al. 2007 guideline for the management of ureteral calculi. J Urol 2007, 178:2418-2434.
55. Willis L.R., Evan A.P., Connors B.A., et al. Relationship between kidney size, renal injury, and renal impairment induced by shock wave lithotripsy. J Am Soc Nephrol 1999, 10:1753-1762.
56. Evan A.P., Willis L.R., Lingeman J.E., et al. Renal trauma and the risk of long-term complications in shock wave lithotripsy. Nephron 1998, 78:1-8.
57. Eassa W.A., Sheir K.Z., Gad H.M., et al. Prospective study of the long-term effects of shock wave lithotripsy on renal function and blood pressure. J Urol 2008, 179:964-968. [discussion: 968-9].
58. Krambeck A.E., LeRoy A.J., Patterson D.E., et al. Longterm outcomes of percutaneous nephrolithotomy compared to shock wave lithotripsy and conservative management. J Urol 2008, 179:2233-2237.
59. Krambeck A.E., Gettman M.T., Rohlinger A.L., et al. Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup. J Urol 2006, 175:1742-1747.
60. Janetschek G., Frauscher F., Knapp R., et al. New onset hypertension after extracorporeal shock wave lithotripsy. Age related incidence and prediction by intrarenal resistive index. J Urol 1997, 158:346-351.
61. Barbosa P.V., Makhlouf A.A., Thorner D., et al. Shock wave lithotripsy associated with greater prevalence of hypertension. Urology 2011, 78(1):22-25.
62. Sato Y., Tanda H., Kato S., et al. Shock wave lithotripsy for renal stones is not associated with hypertension and diabetes mellitus. Urology 2008, 71:586-591. [discussion: 591-2].
63. Elves A.W., Tilling K., Menezes P., et al. Early observations of the effect of extracorporeal shockwave lithotripsy on blood pressure: a prospective randomized control clinical trial. BJU Int 2000, 85:611-615.
64. Krambeck A.E., Rule A.D., Li X., et al. Shock wave lithotripsy is not predictive of hypertension among community stone formers at long-term followup. J Urol 2011, 185:164-169.
65. Willis L.R., Evan A.P., Connors B.A., et al. Prevention of lithotripsy-induced renal injury by pretreating kidneys with low-energy shock waves. J Am Soc Nephrol 2006, 17:663-673.
66. el-Assmy A., el-Nahas A.R., Hekal I.A., et al. Long-term effects of extracorporeal shock wave lithotripsy on renal function: our experience with 156 patients with solitary kidney. J Urol 2008, 179(6):2229-2232.
67. Abdel-Khalek M., Sheir K., Elsobky E., et al. Prognostic factors for extracorporeal shock-wave lithotripsy of ureteric stones-a multivariate analysis study. Scand J Urol Nephrol 2003, 37:413-418.
68. Abdel-Khalek M., Sheir K.Z., Mokhtar A.A., et al. Prediction of success rate after extracorporeal shock-wave lithotripsy of renal stones-a multivariate analysis model. Scand J Urol Nephrol 2004, 38:161-167.
69. Salman M., Al-Ansari A.A., Talib R.A., et al. Prediction of success of extracorporeal shock wave lithotripsy in the treatment of ureteric stones. Int Urol Nephrol 2007, 39:85-89.
70. Hung S.F., Chung S.D., Wang S.M., et al. Chronic kidney disease affects the stone-free rate after extracorporeal shock wave lithotripsy for proximal ureteric stones. BJU Int 2010, 105(8):1162-1167.
71. Seitz C., Fajkovic H., Remzi M., et al. Rapid extracorporeal shock wave lithotripsy treatment after a first colic episode correlates with accelerated ureteral stone clearance. Eur Urol 2006, 49:1099-1105.
72. Tombal B., Mawlawi H., Feyaerts A., et al. Prospective randomized evaluation of emergency extracorporeal shock wave lithotripsy (ESWL) on the short-time outcome of symptomatic ureteral stones. Eur Urol 2005, 47:855-859.
73. Tligui M., El Khadime M.R., Tchala K., et al. Emergency extracorporeal shock wave lithotripsy (ESWL) for obstructing ureteral stones. Eur Urol 2003, 43:552-555.
74. Seitz C., Tanovic E., Kikic Z., et al. Rapid extracorporeal shock wave lithotripsy for proximal ureteral calculi in colic versus noncolic patients. Eur Urol 2007, 52:1223-1227.
75. Madaan S., Joyce A.D. Limitations of extracorporeal shock wave lithotripsy. Curr Opin Urol 2007, 17:109-113.
76. Lee C., Ugarte R., Best S., et al. Impact of renal function on efficacy of extracorporeal shockwave lithotripsy. J Endourol 2007, 21:490-493.
77. Bhatia V., Biyani C.S., al-Awadi K. Extracorporeal shockwave therapy for urolithiasis with renal insufficiency. Urol Int 1995, 55:11-15.
78. Srivastava A., Sinha T., Karan S.C., et al. Assessing the efficiency of extracorporeal shockwave lithotripsy for stones in renal units with impaired function: a prospective controlled study. Urol Res 2006, 34:283-287.
79. Paryani J.P., Ather M.H. Improvement in serum creatinine following definite treatment of urolithiasis in patients with concurrent renal insufficiency. Scand J Urol Nephrol 2002, 36:134-136.
80. Singh I., Gupta N.P., Hemal A.K., et al. Efficacy and outcome of surgical intervention in patients with nephrolithiasis and chronic renal failure. Int Urol Nephrol 2001, 33:293-298.
81. Agrawal M.S., Aron M., Asopa H.S. Endourological renal salvage in patients with calculus nephropathy and advanced uraemia. BJU Int 1999, 84:252-256.
82. Kukreja R., Desai M., Patel S.H., et al. Nephrolithiasis associated with renal insufficiency: factors predicting outcome. J Endourol 2003, 17:875-879.
83. Canes D., Hegarty N.J., Kamoi K., et al. Functional outcomes following percutaneous surgery in the solitary kidney. J Urol 2009, 181:154.
84. Kurien A., Baishya R., Mishra S., et al. The impact of percutaneous nephrolithotomy in patients with chronic kidney disease. J Endourol 2009, 23:1403.
85. Akman T., Binbay M., Aslan R., et al. Long-term outcomes of percutaneous nephrolithotomy in 177 patients with chronic kidney disease: a single center experience. J Urol 2012, 187(1):173-177.
86. Handa R.K., Willis L.R., Connors B.A., et al. Timecourse for recovery of renal function after unilateral (single-tract) percutaneous access in the pig. J Endourol 2010, 24:283.
87. Traxer O., Smith T.G., Pearle M.S., et al. Renal parenchymal injury after standard and mini percutaneous nephrostolithotomy. J Urol 2001, 165:1693.
88. Unsal A., Koca G., Reşorlu B., et al. Effect of percutaneous nephrolithotomy and tract dilatation methods on renal function: assessment by quantitative single-photon emission computed tomography of technetium-99m dimercaptosuccinic acid uptake by the kidneys. J Endourol 2010, 24:1497.
89. Moskovitz B., Halachmi S., Sopov V., et al. Effect of percutaneous nephrolithotripsy on renal function: assessment with quantitative SPECT of 99mTc-DMSA renal scintigraphy. J Endourol 2006, 20:102.
90. Gopalakrishnan G., Prasad G.S. Management of urolithiasis with chronic renal failure. Curr Opin Urol 2007, 17:132-135.
91. Michel M.S., Trojan L., Rassweiler J.J. Complications in percutaneous nephrolithotomy. Eur Urol 2007, 51:899-906.
92. Kukreja R., Desai M., Patel S., et al. Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol 2004, 18:715-722.
93. Troxel S.A., Low R.K. Renal intrapelvic pressure during percutaneous nephrolithotomy and its correlation with the development of postoperative fever. J Urol 2002, 168:1348-1351.
94. Zhong W., Zeng G., Wu K., et al. Does a smaller tract in percutaneous nephrolithotomy contribute to high renal pelvic pressure and postoperative fever?. J Endourol 2008, 22:2147-2151.
95. Joshi H.B., Kumar P.V., Timoney A.G. Citric acid (solution R) irrigation in the treatment of refractory infection (struvite) stone disease: Is it useful?. Eur Urol 2001, 39:586-590.
96. Collins S., Ortiz J., Maruffo F., et al. Expediated struvite-stone dissolution using a high-flow low-pressure irrigation system. J Endourol 2007, 21:1153-1158.
97. Miyaoka R., Ortiz-Alvarado O., Kriedberg C., et al. Correlation between stress and kidney stone disease. J Endourol 2012, 26(5):551-555.
98. Diniz D.H., Schor N., Blay S.L. Stressful life events and painful recurrent colic of renal lithiasis. J Urol 2006, 176(6 Pt 1):2483-2487. [discussion: 2487].
99. Najem G.R., Seebode J.J., Samady A.J., et al. Stressful life events and risk of symptomatic kidney stones. Int J Epidemiol 1997, 26(5):1017-1023.
100. Kessler R.C., Berglund P., Demler O. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
101. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Author, Washington, DC. Revised 4th edition.
102. Angell J., Bryant M., Tu H., et al. Association of depression and urolithiasis. Urology 2012, 79(3):518-525.
103. Chung S.D., Keller J.J., Lin H.C. Increased risk of depressive disorder within 1 year after diagnosis with urinary calculi in Taiwan. Psychiatry Res 2012, [Epub ahead of print].
104. Diniz D.H., Blay S.L., Schor N. Anxiety and depression symptoms in recurrent painful renallithiasis colic. Braz J Med Biol Res 2007, 40(7):949-955.
105. Meyer T., Cooper J., Raspe H. Disabling low back pain and depressive symptoms in the community-dwelling elderly: a prospective study. Spine 2007, 32(21):2380-2386.
106. Diniz D.H., Blay S.L., Schor N. Quality of life of patients with nephrolithiasis and recurrent painful renal colic. Nephron Clin Pract 2007, 106(3):c91-c97.
107. Bensalah K., Tuncel A., Gupta A., et al. Determinants of quality of life for patients with kidney stones. J Urol 2008, 179(6):2238-2243. [discussion: 2243].
108. Penniston K.L., Nakada S.Y. Health related quality of life differs between male and female stone formers. J Urol 2007, 178(6):2435-2440. [discussion: 2440].
109. Bryant M., Angell J., Tu H., et al. Health related quality of life for stone formers. J Urol 2012, 188(2):436-440.
110. Donnally C.J., Gupta A., Bensalah K., et al. Longitudinal evaluation of the SF-36 quality of life questionnaire in patients with kidney stones. Urol Res 2011, 39(2):141-146.
111. Keeley F.X., Assimos D.G. Clinical trials of the surgical management of urolithiasis: current status and future needs. Adv Chronic Kidney Dis 2009, 16(1):65-69.
112. Keeley F.X., Tilling K., Elves A., et al. Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal caliceal stones. BJU Int 2001, 87(1):1-8.
113. Pearle M.S., Lingeman J.E., Leveillee R., et al. Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol 2008, 179(5 Suppl):S69-S73.
114. Albala D.M., Assimos D.G., Clayman R.V., et al. Lower pole I: a prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis-initial results. J Urol 2001, 166(6):2072-2080.
115. Aboumarzouk O.M., Kata S.G., Keeley F.X., et al. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev 2012, (5). CD006029.
116. Nabi G., Cook J., N'Dow J., et al. Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis. BMJ 2007, 334(7593):572.
117. Joshi H.B., Newns N., Stainthorpe A., et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 2003, 169(3):1060-1064.
118. Joshi H.B., Stainthorpe A., Keeley F.X., et al. Indwelling ureteralstents: evaluation of quality of life to aid outcome analysis. J Endourol 2001, 15(2):151-154.
119. Raynal G., Petit J., Saint F. Which efficiency index for urinary stones treatment?. Urol Res 2009, 37(4):237-239.
120. Lipkin M.E., Preminger G.M. Demystifying the medical management of nephrolithiasis. Rev Urol 2011, 13(1):34-38.
121. Fink H.A., Akornor J.W., Garimella P.S., et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 2009, 56(1):72-80.
122. Ortiz-Alvarado O., Miyaoka R., Kriedberg C., et al. Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers. J Endourol 2011, 25(3):535-540.
123. Robinson M.R., Leitao V.A., Haleblian G.E., et al. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation. J Urol 2009, 181(3):1145-1150.